Form D — Cyclacel Pharmaceuticals, Inc.
0001829126-25-001006 · filed 2025-02-14
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $0
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cyclacel Pharmaceuticals, Inc.
- CIK
- 1130166
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS, NJ 07922 - Phone
- 908-517-7330
Related persons
-
David Lazar · Executive OfficerBerkeley Heights, NJ
-
David Natan · DirectorBerkeley Heights, NJ
-
Avraham Ben-Tzvi · DirectorBerkeley Heights, NJ
-
Spiro Rombotis · DirectorBerkeley Heights, NJ
-
Paul McBarron · DirectorBerkeley Heights, NJ
-
Samuel Barker · DirectorBerkeley Heights, NJ
View original on SEC EDGAR.